Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04684784
Other study ID # DNEMG
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date January 4, 2021
Est. completion date February 18, 2021

Study information

Verified date December 2020
Source University of Castilla-La Mancha
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Brief summary: The purpose of this study is to determine the effect of Dry Needling (DN) on electromyographic activity in different situations at the latent trigger point (LTrP) point of the upper trapezius. Randomized controlled trial, in parallel with the crossover control design. Two groups with LTrP in the upper trapezius, and the DN group or the Sham-Dn group will be randomly selected.


Recruitment information / eligibility

Status Completed
Enrollment 46
Est. completion date February 18, 2021
Est. primary completion date February 4, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 30 Years
Eligibility Inclusion Criteria: - Age between 18 and 30 years - The presence of LTrP in the middle third of the upper trapezius muscle onthe dominant side - Being able to provide written informed consent - Being able to follow instructions and realize clinical tests Exclusion Criteria: - Any pharmacological therapeutic - Any medical treatment or physical therapies at cervical region during the 6-month before this study - Any diagnosed health problem - Any history of head and upper extremity surgery or trauma - Any red flags to DN, (ie: metabolic diseases, pregnancy, kinesiophobia,Infection, cancer)• Absence of recurrent history of neck pain - No neck pain symptomatology the previous 6 months - Cervical disk herniation

Study Design


Intervention

Device:
Intervention-Dry Needling
Deep Dry Needling into the site of the latent TriggerPoint of the upper trapezius muscle. 1 session in upper trapezius muscle moving the needle up and down ten times.
Control-Dry Needling
Sham Dry Needling into the site of the latent Trigger Point of the upper trapezius muscle with non-penetrating needles

Locations

Country Name City State
Spain Performance and Sport Rehabilitation Laboratory Toledo

Sponsors (1)

Lead Sponsor Collaborator
University of Castilla-La Mancha

Country where clinical trial is conducted

Spain, 

Outcome

Type Measure Description Time frame Safety issue
Primary Changes in resting surface EMG activity (amplitude, RMS) EMG activity (RMS) of the upper trapezius after dry needling or sham needling as assessed by the EMG ME 6000 TE(Mega Electronics, Kuopio, Finland). Resting EMG activity will be expressed as a percentage of maximal reference contractions of the upper trapezius (% reference contractions). Baseline, at 30 minutes after treatment, at 24 hours after treatment, at 72 hours after treatment
Secondary Changes in resting surface EMG activity (Median frequency, MF) EMG activity (RMS) of the upper trapezius after dry needling or sham needling as assessed by the EMG ME 6000 TE(Mega Electronics, Kuopio, Finland).
EMG median frequency will be used to determine the endurance of the upper trapezius. The EMG median frequency will be measured in Hertz (Hz).
Baseline, at 30 minutes after treatment, at 24 hours after treatment, at 72 hours after treatment
Secondary Changes in submaximal contrations surface EMG activity of upper trapezius (amplitude, RMS) EMG activity (RMS) of the upper trapezius after dry needling or sham needling as assessed by the EMG ME 6000 TE(Mega Electronics, Kuopio, Finland).
EMG activity of submaximal contractions will be expressed as a percentage of submaximal reference contractions of the upper trapezius (% reference contractions).
Baseline, at 30 minutes after treatment, at 24 hours after treatment, at 7submaximal contractions EMG activity will be expressed as a percentage of maximal reference contractions of the upper trapezius (% reference contractions).2 hours after treatment
Secondary Changes in submaximal contrations surface EMG activity of upper trapezius (Median frequency, MF) EMG activity (RMS) of the upper trapezius after dry needling or sham needling as assessed by the EMG ME 6000 TE(Mega Electronics, Kuopio, Finland).
EMG median frequency will be used to determine the endurance of the upper trapezius. The EMG median frequency will be measured in Hertz (Hz).
Baseline, at 30 minutes after treatment, at 24 hours after treatment, at 72 hours after treatment
Secondary Change in Pain Pressure Threshold (PPT) Pressure-Pain Threshold as assessed by an manual mechanical algometer. PPT is the minimal amount of pressure that produces pain and is used to assess abnormalities in nociceptive processing or hyperalgesia. Baseline, at 30 minutes after treatment, at 24 hours after treatment, at 72 hours after treatment
See also
  Status Clinical Trial Phase
Completed NCT04157439 - Manual Treatment Regimens in Upper Trapezius Trigger Point N/A
Completed NCT04559906 - Spray Stretch Technique Versus Sustain Pressure for Trapezius Triggers N/A
Completed NCT04157426 - Percutaneous Electrolysis Versus Dry Needling in Levator Scapulae N/A
Enrolling by invitation NCT06029413 - Myo vs. Myofascial Injection for Myofascial Trigger Points N/A
Recruiting NCT06051799 - Effects of Pressure Release of Myofascial Trigger Points on Mechanical Neck Pain. N/A
Completed NCT04285216 - Effects of Dry Needling and Strain Counter Strain Technique in Myofascial Trigger Points of Upper Trapezius N/A
Completed NCT03273985 - Effectiveness of Dry Needling in Shortened Triceps Surae Muscle N/A
Not yet recruiting NCT05995639 - Dry Needling Versus Ozone in Myofascial Pain Syndrome N/A
Active, not recruiting NCT04108390 - Gluteus Medius Dry Needling and Ankle Instability N/A
Completed NCT03689283 - The Effect of Dry Needling on Muscle Stiffness, Gait, Motion, and Strength in Healthy Individuals With Trigger Points N/A
Completed NCT03888586 - Comparison of Dry Needling and Deep Friction Massage in Patients With Subacromial Pain Syndrome N/A
Completed NCT05185050 - Prevalence of Myofascial Pain Syndrome in Adolescent Idiopathic Scoliosis
Completed NCT04823013 - Comparison of High Power Pain Threshold Ultrasound and Ischemic Compression Techniques for Treatment of Trigger Points N/A
Completed NCT04832074 - Immediate Stiffness Changes in Myofascial Trigger Points After Dry Needling N/A
Completed NCT05879016 - Different Taping Methods in Myofascial Pain Syndrome N/A
Recruiting NCT05535010 - The Effect of the Presence of Active Trigger Points in the Muscles Innervated by the Affected Nerve Roots on the Treatment Results of Transforaminal Epidural Steroid Injection in Patients With Lumbar Radiculopathy. N/A
Completed NCT04316793 - Effects of Dry Needling When Applied to the Infraspinatus Muscle in People With Chronic Shoulder Pain N/A
Completed NCT05279794 - Efficacy of Two Types of Non-invasive Erector Spinae Muscle Taut Band Therapy in University Students With Low Back Pain N/A
Not yet recruiting NCT05688800 - Pressure Release Versus Thoracic Manipulation in Rhomboids MPS N/A
Completed NCT05265468 - Noninvasive Treatment of Upper Trapezius Active Trigger Points in College Students With Neck Pain N/A